Novo Nordisk - Alzheimer's unbranded disease awareness

Novo Nordisk is on the cusp of launching their new indication for semaglutide in Alzheimer's Disease, which can be effective in slowing the onset of disease - but only if Alzheimer's is identified and treated early.

The brief for this campaign was to encourage higher recognition of the potential early signs of Alzheimer's Disease in both people with the condition and with caregivers.